🇺🇸 FDA
Pipeline program

4D-125 IVT Injection

4D-125-C001

Phase 2 mab active

Quick answer

4D-125 IVT Injection for X-Linked Retinitis Pigmentosa is a Phase 2 program (mab) at 4D Molecular Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
4D Molecular Therapeutics
Indication
X-Linked Retinitis Pigmentosa
Phase
Phase 2
Modality
mab
Status
active

Clinical trials